Li Wu

7PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsMolecular targetsMolecular medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 11, 2026
Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway.

Suzhou Huang, Yiheng Zhang, Tianle Ma

|Nov 23, 2023
Comparative pharmacokinetics of 11 major bioactive components between two dosage forms of Qixue Shuangbu Prescription in rats by ultra-high-performance liquid chromatography-tandem mass spectrometry.

Yong Jiang, Liu Xu, Nina Wei

|Dec 30, 2021
Study on the material basis of Dahuang Zhechong pill of anti-hepatoma effect by promoting vascular normalization.

Honglin Chen, Furong Yang, Chuankui Fu

|Dec 10, 2021
Preparation of a Self-Assembled Rhein-Doxorubicin Nanogel Targeting Mitochondria and Investigation on Its Antihepatoma Activity.

Li Wu, Yan Shi, Zihui Ni

|Nov 30, 2018
Rhein reverses doxorubicin resistance in SMMC-7721 liver cancer cells by inhibiting energy metabolism and inducing mitochondrial permeability transition pore opening.

Li Wu, Kexin Cao, Zihui Ni

|Nov 01, 2018
Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells.

Li Wu, Xiao Liu, Ke Xin Cao

Pageof 2

Frequent Collaborators

1 joint publications

Zhipeng Chen

1 joint publications

Honglin Chen

1 joint publications

Furong Yang

1 joint publications

Chuankui Fu